Infusion & Chemotherapy №1 2022

TITLE

CONTENTS

NEWSLETTER

Yu.I. Feshchenko, V.G. Matusevych
“Invest to end tuberculosis. Save a life”. To World Tuberculosis Day March 24, 2022

DOI: 10.32902/2663-0338-2022-1-5-6

ORIGINAL STUDIES

Yu.I. Feshchenko, М.S. Opanasenko, I.V. Liskina, S.M. Bilokon, O.V. Tereshkovych, B.М. Konik, L.I. Levanda, L.M. Zagaba, M.Yu. Shamray, M.I. Kalenychenko, V.I. Lysenko, S.М. Shalagay
Lung lever after COVID-19: clinical-X-ray, surgical and morphological characteristics

DOI: 10.32902/2663-0338-2022-1-7-15

O.K. Yakovenko, Ya.O. Dziublyk, M.I. Lynnyk
Determination of dynamics and stage of development of COVID-19 pneumonia based on digital software processing of images of computed tomography of the chest

DOI: 10.32902/2663-0338-2022-1-16-22

REVIEW ARTICLE

M.M. Ostrovskyi, L.I. Konopkina, K.Yu. Gashynova, G.L. Gumeniuk, D.V. Dobrianskyi, O.L. Bororova
Pathogenetic treatment of patients with COVID-19 at the outpatient stage

DOI: 10.32902/2663-0338-2022-1-23-31

M.V. Bondar, M.M. Pylypenko, O.A. Loskutov
Endothelium is the main target of coronavirus infection

DOI: 10.32902/2663-0338-2022-1-32-39

CLINICAL CASE

О.М. Raznatovska, Yu.V. Myronchuk, O.S. Shalmin, A.V. Fedorec
Clinical case of concomitant tuberculosis and COVID-19 on the background of Churg-Strauss syndrome

DOI: 10.32902/2663-0338-2022-1-40-46

FOREIGN EXPERIENCE

E. Puterman, B. Hives, N. Mazara, N. Grishin, J. Webster, S. Hutton, M.S. Koehle, Y. Liu, M.R. Beauchamp
COVID‑19 Pandemic and Exercise (COPE) trial: a multigroup pragmatic randomised controlled trial examining effects of app-based at-home exercise programs on depressive symptoms

DIGEST

REQUIREMENTS FOR AUTHORS

National Institute of Phthisiology and Pulmonology

named after F.G. Yanovsky NAMS of Ukraine

http://www.ifp.kiev.ua/doc/journals/ic_ukr.htm

24/05/2022